Screening for Modulators of Aggregation with a Microplate Elongation Assay

Methods in Enzymology

Volumn 413, Issue , 2006, Pages 313-325

  Berthelier, Valerie ^a   Wetzel, Ronald ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ETHINYLESTRADIOL; GOSSYPOL ACETIC ACID; GUAIAZULENE; LATAMOXEF; MERBROMIN; METACYCLINE; MONOMER; PROTOPORPHYRIN;

CHEMICAL REACTION; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DETERMINATION; PROTEIN FOLDING; REACTION ANALYSIS; REVIEW;

AMYLOID BETA-PROTEIN; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PEPTIDES; PROTEIN STRUCTURE, QUATERNARY;

EID: 33749521675     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(06)13016-5     Document Type: Review

References (30)

1. Apostol B.L., Kazantsev A., Raffioni S., Illes K., Pallos J., Bodai L., Slepko N., Bear J.E., Gertler F.B., Hersch S., Housman D.E., Marsh J.L., and Thompson L.M. A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc. Natl. Acad. Sci. USA 100 (2003) 5950-5955
2. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
3. Bayer T.A., Wirths O., Majtenyi K., Hartmann T., Multhaup G., Beyreuther K., and Czech C. Key factors in Alzheimer's disease: Beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 11 (2001) 1-11
4. Bence N.F., Sampat R.M., and Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292 (2001) 1552-1555
5. Berthelier V., Hamilton J.B., Chen S., and Wetzel R. A microtiter plate assay for polyglutamine aggregate extension. Anal. Biochem. 295 (2001) 227-236
6. Berthelier V., and Wetzel R. An assay for characterizing in vitro the kinetics of polyglutamine aggregation. Methods Mol. Biol. 217 (2003) 295-303
7. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. USA 100 (2003) 330-335
8. Caughey B., and Lansbury P.T. Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders. Annu. Rev. Neurosci. 26 (2003) 267-298
9. Demuro A., Mina E., Kayed R., Milton S.C., Parker I., and Glabe C.G. Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J. Biol. Chem. 280 (2005) 17294-17300
10. Esler W.P., Stimson E.R., Jennings J.M., Vinters H.V., Ghilardi J.R., Lee J.P., Mantyh P.W., and Maggio J.E. Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 39 (2000) 6288-6295
11. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., and Goldstein L.S. Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron 40 (2003) 25-40
12. Guo J.-T., Hall C.K., Xu Y., and Wetzel R. Modeling Protein Aggregate Assembly and Structure. In: Xu Y., Xu D., and Liang J. (Eds). "Computational Methods for Protein Structure Prediction and Modeling" (2005), Springer Press
13. Heiser V., Engemann S., Brocker W., Dunkel I., Boeddrich A., Waelter S., Nordhoff E., Lurz R., Schugardt N., Rautenberg S., Herhaus C., Barnickel G., Bottcher H., Lehrach H., and Wanker E.E. Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay. Proc. Natl. Acad. Sci. USA 99 Suppl. 4 (2002) 16400-16406
14. Heiser V., Scherzinger E., Boeddrich A., Nordhoff E., Lurz R., Schugardt N., Lehrach H., and Wanker E.E. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy. Proc. Natl. Acad. Sci. USA 97 (2000) 6739-6744
15. Hemmila I., Dakubu S., Mukkala V.M., Siitari H., and Lovgren T. Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137 (1984) 335-343
16. Hughes R.E., Lo R.S., Davis C., Strand A.D., Neal C.L., Olson J.M., and Fields S. Altered transcription in yeast expressing expanded polyglutamine. Proc. Natl. Acad. Sci. USA 98 (2001) 13201-13206
17. Lashuel H.A., Hartley D., Petre B.M., Walz T., and Lansbury Jr. P.T. Neurodegenerative disease: Amyloid pores from pathogenic mutations. Nature 418 (2002) 291
18. Lashuel H.A., Hartley D.M., Balakhaneh D., Aggarwal A., Teichberg S., and Callaway D.J. New class of inhibitors of amyloid-beta fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease. J. Biol. Chem. 277 (2002) 42881-42890
19. McLaurin J., Cecal R., Kierstead M.E., Tian X., Phinney A.L., Manea M., French J.E., Lambermon M.H., Darabie A.A., Brown M.E., Janus C., Chishti M.A., Horne P., Westaway D., Fraser P.E., Mount H.T., Przybylski M., and St. George-Hyslop P. Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis. Nat. Med. 8 (2002) 1263-1269
20. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
21. Poirier M.A., Li H., Macosko J., Cai S., Amzel M., and Ross C.A. Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilization. J. Biol. Chem. 277 (2002) 41032-41037
22. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castano E.M., and Frangione B. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy. Nat. Med. 4 (1998) 822-826
23. Stockwell B.R. Chemical genetic screening approaches to neurobiology. Neuron 36 (2002) 559-562
24. Temussi P.A., Masino L., and Pastore A. From Alzheimer to Huntington: Why is a structural understanding so difficult?. EMBO J. 22 (2003) 355-361
25. Walsh D.M., and Selkoe D.J. Oligomers on the brain: The emerging role of soluble protein aggregates in neurodegeneration. Protein Pept. Lett. 11 (2004) 213-228
26. Wetzel R. Protein folding and aggregation in the expanded polyglutamine repeat diseases. In: Buchner J., and Kiefhaber T. (Eds). "The Protein Folding Handbook" (2005), Wiley Wiley press, N.Y
27. Wetzel R. Chemical and physical properties of polyglutamine repeat sequences. In: Wells R., and Ashizawa T. (Eds). "Genetic Instabilities and Neurological Diseases" (2006), Elsevier, San Diego Elsevier-Academic press, San Diego
28. Williams A.D., Portelius E., Kheterpal I., Guo J.T., Cook K.D., Xu Y., and Wetzel R. Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. J. Mol. Biol. 335 (2004) 833-842
29. Williams A.D., Sega M., Chen M., Kheterpal I., Geva M., Berthelier V., Kaleta D.T., Cook K.D., and Wetzel R. Structural properties of Abeta protofibrils stabilized by a small molecule. Proc. Natl. Acad. Sci. USA 102 (2005) 7115-7120
30. Wood S.J., MacKenzie L., Maleeff B., Hurle M.R., and Wetzel R. Selective inhibition of βA4 fibril formation. J. Biol. Chem. 271 (1996) 4086-4092 1996